Us Congress 2023-2024 Regular Session

Us Congress House Bill HB10135

Introduced
11/15/24  

Caption

Improving Diagnosis in Medicine Act of 2024

Impact

The bill introduces several new provisions that directly influence state and federal healthcare policies. Notably, it authorizes appropriations for research explicitly targeting diagnostic safety, which may shift resource allocation within healthcare budgets. By fostering collaborations between academic institutions and clinical practice locations, the act aims to create a robust knowledge base that informs practical improvements in diagnostic protocols across the nation. The establishment of an Interagency Council also suggests a move towards a more coordinated federal approach to healthcare challenges related to diagnostics, which can significantly streamline research efforts and funding distribution.

Summary

House Bill 10135, titled the 'Improving Diagnosis in Medicine Act of 2024', aims to enhance the quality and safety of diagnoses within the healthcare system. This legislation seeks to tackle diagnostic errors, including delays and misinterpretations that can lead to significant patient harm. By establishing comprehensive research programs and providing financial assistance for new and existing diagnostic centers, the bill emphasizes the importance of understanding and ameliorating failures in the diagnostic process. It builds upon existing frameworks in the Public Health Service Act to ensure that diagnostic quality is grounded in evidence-based strategies.

Contention

While the bill promises to advance diagnostic practices, it may also spark discussions on the adequacy of funding and the effectiveness of proposed strategies. Stakeholders might raise concerns regarding the potential bureaucratic complexities introduced by the interagency coordination effort. Questions may arise about how effectively research findings will translate into practical changes in healthcare settings and whether all regions, particularly underserved areas, will benefit equally from the improvements targeted by the bill. Moreover, ensuring that diverse healthcare stakeholders are adequately represented in the dialogue surrounding diagnostic quality will be crucial in implementing the bill's objectives.

Companion Bills

No companion bills found.

Similar Bills

US SB5613

A bill to improve the quality, appropriateness, and effectiveness of diagnosis in health care, and for other purposes.

US SB4246

Advancing Menopause Care and Mid-Life Women’s Health Act

US HR1514

Recognizing that cancer patients have the right to receive care that ensures effective prevention, early diagnosis, improved outcomes, optimal patient rehabilitation, and affordable health care.

US SB139

Advancing FASD Research, Services and Prevention Act or the FASD Respect ActThis bill reauthorizes and modifies programs that are administered by the Department of Health and Human Services (HHS) to address fetal alcohol spectrum disorders (FASD), including educational and research programs.The bill also establishes FASD Centers for Excellence to support FASD prevention, such as through screenings, public awareness campaigns, and trainings, particularly at the state and local levels.

US HR1356

Expressing support for the designation of October 9 through October 16, 2024, as "National Dyspraxia/Developmental Coordination Disorder (DCD) Awareness Week" and a commitment to raise awareness of dyspraxia/DCD in the United States.

US HB10297

Thyroid Disease CARE Act of 2024 Thyroid Disease Coverage, Awareness, Research, and Education Act of 2024

US SR590

A resolution designating March 15, 2024, as "Long COVID Awareness Day".

US SB755

Finn Sawyer Access to Cancer Testing Act This bill provides for coverage of certain cancer diagnostic and laboratory tests under Medicare, Medicaid, and the Children's Health Insurance Program (CHIP). Specifically, the bill provides for coverage of microarray analysis, DNA and RNA sequencing, whole-exome sequencing, and other next-generation sequencing for individuals diagnosed with cancer. Additionally, the Department of Health and Human Services must establish an education and awareness program for physicians and the public about genomic testing and the role of genetic counselors.